Cary Gentry, MD
Colon & Rectal Surgery · Richmond, VANPI 1043386519
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,107 and has fallen 70.4% since, to $328 in 2025.
Across 161 payments — averaging $26.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$921
- Medtronic$637
- Johnson & Johnson$369
- Takeda Pharmaceuticals U.S.A., Inc.$299
- Merck$272
- Ferring Pharmaceuticals Inc.$200
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,207100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 41 | $921 |
| Medtronic(2 entities) | 12 | $637 |
| Johnson & Johnson | 9 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $299 |
| Merck | 10 | $272 |
| Ferring Pharmaceuticals Inc. | 13 | $200 |
| Braintree Laboratories, Inc. | 10 | $195 |
| Innovation Technologies Inc | 2 | $173 |
| Davol Inc. | 2 | $139 |
| Dilon Technologies, Inc. | 2 | $97 |
| Vertex | 4 | $85 |
| Axonics, Inc. | 5 | $84 |
| Mallinckrodt Enterprises LLC | 4 | $82 |
| Boston Scientific | 4 | $82 |
| Pacira Pharmaceuticals Incorporated | 5 | $79 |
| Integra Lifesciences Corporation | 3 | $66 |
| Baudax Bio Inc. | 3 | $53 |
| Shire North American Group Inc | 2 | $53 |
| La Jolla Pharmaceutical Company | 3 | $44 |
| Mallinckrodt Hospital Products Inc. | 2 | $43 |
| THD America, Inc. | 3 | $32 |
| Mimedx Group, Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Stryker | 1 | $26 |
| Sanara Medtech Inc. | 1 | $20 |
| Vantage Technology LLC | 1 | $20 |
| Trevena, Inc. | 1 | $16 |
| Vioptix Inc | 1 | $15 |
| Intuitive Surgical | 1 | $15 |
| Palette Life Sciences, Inc. | 1 | $12 |
| Romark Laboratories, LC | 1 | $11 |
| Reprise Biomedical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$258
- Irrisept$148
- HARMONIC Product Family$121
- Echelon Powered Circular$121
- GATTEX$113
- PHASIX$111
- BRIDION$100
- XIFAXAN$100
How this compares
$4,207 in reported general payments places this provider in the 70th percentile of 46 colon & rectal surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 68 | $4,865 |
| Mesalamine ErMesalamine | 18 | $1,629 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 13 | $1,583 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 67 | $933 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 38 | $826 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $219 |
| Oxycodone Hcl | 14 | $52 |
| Ondansetron Hcl | 33 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Suflave | $195 | $1,58313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 46 colon & rectal surgery providers in Virginia.
Other colon & rectal surgery in Richmond
- Andrew VorenbergRichmond$560K
- Emily RivetRichmond$5K
- Jaime BohlRichmond$5K
- Peter MillerRichmond$4K
- Stacy RansonRichmond$2K
- Paul CharronRichmond$1K
- William TimmermanRichmond$1K
- Nishit ShahRichmond$1K
- Beshoy FahmyRichmond$399
- Crawford SmithRichmond$286
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.